Surface brachytherapy: Joint report of the AAPM and the GEC‐ESTRO Task Group No. 253

Fulkerson, Regina K.; Pérez‐Calatayud, José; Ballester, F.; Buzurović, Ivan; Kim, Yongbok; Niatsetski, Yury; Ouhib, Zoubir; Pai, Sujatha; Rivard, Mark J.; Rong, Yi; Siebert, F.A.; Thomadsen, Bruce R.; Weigand, Frank

doi:10.1002/mp.14436

Cited by 25 publications

(27 citation statements)

References 89 publications

(258 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The two-year outcomes of our study are very encouraging and confirm the results of previous analyses reporting favorable outcomes after cHDR-RT of NMSC (16). More generally, ours and other reports show that cHDR-RT represents an effective and safe therapeutic option for NMSCs, as confirmed by their inclusion in several international guidelines published in recent years (17)(18). Moreover, some literature reviews confirmed that cHDR-RT is effective in NMSC treatment, with around 97% local control rate and 94.8% excellent or good cosmetic results even in elderly patients (19,20).…”

Section: Discussionsupporting

confidence: 90%

Non-melanoma Skin Cancer Treated by Contact High-dose-rate Radiotherapy (Brachytherapy): A Mono-institutional Series and Literature Review

Tagliaferri

Ciardo

Fionda

et al. 2021

In Vivo

View full text Add to dashboard Cite

Background/Aim: Non-melanoma skin cancers (NMSC) are the most common neoplasms worldwide and their incidence has been proven to increase in recent years and their treatment should aim at cancer cure as well as cosmetic and functional results. The aim of the study was to report the results of our mono-institutional series of highdose-rate radiotherapy (cHDR-RT) in NMSC, based on a homogenous technique and two different treatment schedules. Patients and Methods: All patients affected by NMSC who were consecutively evaluated and treated at our Interventional Oncology Center from October 2018 to August 2020, were included. Patients underwent cHDR-RT using flap applicators and remotely afterloaded Ir-192 sources. Results: Overall, 51 patients were treated for a total of 67 lesions. Local control (LC) and disease-specific survival (DSS) were 94.0% and 100%, respectively. Grade 1, grade 2, grade 3 and grade 4 acute toxicity rates were 24.6%, 3.5%, 3.5%, and 0.0%, respectively. The cosmetic results were graded as excellent/good, fair, and poor in 73.7%, 19.3%, and 7.0%. Conclusion: cHDR-RT of NMSC is an effective alternative to surgery due to excellent outcomes both in terms of local control and aesthetic results especially in the face.Non-melanoma skin cancers (NMSC) are the most common neoplasms worldwide and their incidence has been proven to increase in the recent years (1). The two most frequent NMSC are squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). Albeit with a better prognosis than other cancers, the NMSC treatment strategies should be properly selected considering the possible negative impact on quality of life of suboptimal cosmetic results (2). Therefore, treatment of NMSC should aim at cancer cure as well as cosmetic and functional results (3). Therapeutic options include surgery, radiotherapy (RT), and topical agents. More recently for locally advanced or metastatic tumors where curative surgery and curative radiotherapy are not feasible, 2313This article is freely accessible online.

show abstract

Section: Discussionsupporting

confidence: 90%

Non-melanoma Skin Cancer Treated by Contact High-dose-rate Radiotherapy (Brachytherapy): A Mono-institutional Series and Literature Review

Tagliaferri

Ciardo

Fionda

et al. 2021

In Vivo

View full text Add to dashboard Cite

show abstract

“…The source is a vacuum tube (10 mm in length, 2 mm in diameter) encased in a cooling catheter (5.6 mm diameter). It is typically operated at 50 kVp with 300 μA of electrons striking a thin tungsten film target on the inner surface of a ceramic X-ray-transparent anode ( 24 ).…”

Section: Methodsmentioning

confidence: 99%

Feasibility of electronic brachytherapy in cervix cancer–A dosimetric comparison of different brachytherapy techniques

et al. 2022

View full text Add to dashboard Cite

“…Flexible, flap-like applicators are commercially available. These are a viable option for some large skin cases, due to consistent catheter spacing and flexibility as well as the ability to cut the flap to specific dimensions or affix it to other immobilization devices to improve reproducibility [23]. However, the flap applicators limit how close the sources can approach the skin and how well the flap geometry conforms to rapidly varying skin topology.…”

Section: Traditional Applicators -Benefits and Drawbacksmentioning

confidence: 99%

“…There is a growing interest in the development of AM applicators for skin BT. There is, however, a lack of review articles, and the latest guidance document from AAPM and GEC-ESTRO acknowledges that neither a standard of care nor comprehensive guideline exists yet for surface brachytherapy, let alone the inclusion of AM applicators [23].…”

Section: Clinical Need For Additive Manufacturing Applicatorsmentioning

confidence: 99%

Additive manufacturing (3D printing) in superficial brachytherapy

Bellis¹,

Rembielak²,

Barnes³

et al. 2021

jcb

View full text Add to dashboard Cite

The aim of this work is to provide an overview of the current state of additive manufacturing (AM), commonly known as 3D printing, within superficial brachytherapy (BT). Several comprehensive database searches were performed to find publications linked to AM in superficial BT. Twenty-eight core publications were found, which can be grouped under general categories of clinical cases, physical and dosimetric evaluations, proof-of-concept cases, design process assessments, and economic feasibility studies. Each study demonstrated a success regarding AM implementation and collectively, they provided benefits over traditional applicator fabrication techniques. Publications of AM in superficial BT have increased significantly in the last 5 years. This is likely due to associated efficiency and consistency benefits; though, more evidences are needed to determine the true extent of these benefits.

show abstract

Surface brachytherapy: Joint report of the AAPM and the GEC‐ESTRO Task Group No. 253

Cited by 25 publications

References 89 publications

Non-melanoma Skin Cancer Treated by Contact High-dose-rate Radiotherapy (Brachytherapy): A Mono-institutional Series and Literature Review

Non-melanoma Skin Cancer Treated by Contact High-dose-rate Radiotherapy (Brachytherapy): A Mono-institutional Series and Literature Review

Feasibility of electronic brachytherapy in cervix cancer–A dosimetric comparison of different brachytherapy techniques

Additive manufacturing (3D printing) in superficial brachytherapy

Contact Info

Product

Resources

About